Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibody”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03639935
What this trial is testing

Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy

Who this might be right for
Biliary Tract Cancer
University of Michigan Rogel Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT03155425
What this trial is testing

PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma, Adult
Jiangsu HengRui Medicine Co., Ltd. 75
Testing effectiveness (Phase 2)Looking for participantsNCT06979908
What this trial is testing

A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The First Hospital of Jilin University 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04652076
What this trial is testing

GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab

Who this might be right for
Endometrial CarcinomaCervix Carcinoma
NETRIS Pharma 240
Testing effectiveness (Phase 2)UnknownNCT04888611
What this trial is testing

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Huashan Hospital 40
Early research (Phase 1)WithdrawnNCT02357732
What this trial is testing

Study of the Anti-PD-1 Antibody Nivolumab in Combination With Dabrafenib and/or Trametinib

Who this might be right for
Metastatic Melanoma
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT03171064
What this trial is testing

Exercise as a Supportive Measure for Patients Undergoing Checkpoint-inhibitor Treatment

Who this might be right for
PD-1 AntibodiesExerciseMelanoma
University Hospital Heidelberg 39
Not applicableUnknownNCT03722875
What this trial is testing

SHR-1210 Plus Apatinib in Patients With Hepatocellular Carcinoma After Surgery

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 45
Large-scale testing (Phase 3)UnknownNCT05661240
What this trial is testing

Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody Treatment

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 348
Not applicableLooking for participantsNCT06323382
What this trial is testing

Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaAnti-PD1/PDL1 AntibodyBevacizumab
Sun Yat-sen University 240
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507526
What this trial is testing

Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
Sun Yat-sen University 76
Testing effectiveness (Phase 2)Ended earlyNCT02452424
What this trial is testing

A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+2 more
Daiichi Sankyo 78
Testing effectiveness (Phase 2)Study completedNCT04834674
What this trial is testing

DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaTransarterial ChemoembolizationApatinib+1 more
Sichuan Cancer Hospital and Research Institute 20
Testing effectiveness (Phase 2)UnknownNCT04749485
What this trial is testing

HX008 for the Treatment of Patients With Malignant Melanoma

Who this might be right for
Melanoma
Taizhou Hanzhong biomedical co. LTD 119
Large-scale testing (Phase 3)Study completedNCT03430297
What this trial is testing

A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma

Who this might be right for
Metastatic MelanomaUnresectable Melanoma
Shanghai Junshi Bioscience Co., Ltd. 256
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07138989
What this trial is testing

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 10
Large-scale testing (Phase 3)UnknownNCT04084626
What this trial is testing

PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV

Who this might be right for
EBV Infection
Beijing Friendship Hospital 40
Early research (Phase 1)UnknownNCT04756934
What this trial is testing

HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma

Who this might be right for
Melanoma
Taizhou HoudeAoke Biomedical Co., Ltd. 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469306
What this trial is testing

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Fujian Cancer Hospital 130
Large-scale testing (Phase 3)Study completedNCT04063163
What this trial is testing

A Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy in Patients With ES-SCLC

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Shanghai Henlius Biotech 585
Next Page